ABBV vs SDGR · P/E 81, rev $61.16B vs rev $207.5M
AbbVie Inc (ABBV) versus Schrodinger Inc (SDGR) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Schrodinger Inc (SDGR) is a health information services company listed on NASDAQ.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported SDGR revenue for 2024-12-31 was $207.5M. Net income was -$187.1M. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. SDGR currently screens at market cap $1.16B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. SDGR currently screens at market cap $1.16B.
Not investment advice. Open the ABBV and SDGR stock pages for the full models.
Not investment advice.